According to the research report, the global 3Dbioprinting size is expected to touch USD 8.3 Billion by 2030, from USD 2 Billion in 2021, growing with a significant CAGR of 18.51% from 2022 to 2030.
The 3D bioprinting market report offers a comprehensive study of
the current state expected at the major drivers, market strategies, and key
vendors’ growth. The report presents energetic visions to conclude and study
the market size, market hopes, and competitive surroundings. The research also
focuses on the important achievements of the market, research & development,
and regional growth of the leading competitors operating in the market. The
current trends of the global 3D bioprinting market in conjunction with the geographical
landscape of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global 3D bioprinting market, which aids companies operating in the
market in making strategic development decisions. The study also elaborates on
significant changes that are highly anticipated to configure growth of the
global 3D bioprinting market during the
forecast period. It also includes a key indicator assessment that highlights
growth prospects of this market and estimates statistics related to growth of
the market in terms of value (US$ Mn) and volume (tons).
Sample Link https://www.precedenceresearch.com/sample/2107
Report Scope of the 3D Bioprinting Market
| Report Coverage | Details |
| Market Size in 2022 | USD 2.13 Billion |
| Market Size by 2030 | USD 8.3 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 18.51% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Component, Technology, Application, End User, and Geography |
This study covers a detailed segmentation
of the global 3D bioprinting market,
along with key information and a competition outlook. The report mentions
company profiles of players that are currently dominating the global 3D
bioprinting market, wherein various
developments, expansions, and winning strategies practiced and implemented by
leading players have been presented in detail.
Key Players
- 3D Bioprinting Solutions
- Advanced Solutions Life Sciences, LLC
- Allevi Inc.
- Aspect Biosystems Ltd.
- Bico group ab
- Bio3D Technologies Pte. Ltd.
- Cellink Global
- Collplant Biotechnologies Ltd.
- Cyfuse Biomedical K.K.
- Electro Optical Systems
- EnvisionTEC, Inc.
- Foldink Life Science Technologies
- Formlabs, Inc.
- GE Healthcare
- Inventia Life Science PTY LTD
- Optomec Inc.
- Organovo Holdings Inc
- Pandorum Technologies pvt. ltd.
- Poietis
- Precise Bio
- Regenovo Biotechnology Co. Ltd.
- Renishaw plc.
- Revotek co., ltd.
- Rokit Healthcare, inc.
- Stratasys Ltd.Vivax Bio, LLC
Market Segmentation
By Component
- 3D Bioprinters
- Bioinks
By Technology
- Magnetic Levitation
- Inkjet-based
- Syringe-based
- Laser-based
- Others
By Application
- Research Applications
- Clinical Applications
By End User
- Research Organizations and Academic Institutes
- Biopharmaceutical companies
- Hospitals
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Research Methodology
The research methodology adopted by
analysts for compiling the global 3D bioprinting market report is based on detailed primary as
well as secondary research. With the help of in-depth insights of the
market-affiliated information that is obtained and legitimated by
market-admissible resources, analysts have offered riveting observations and
authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global 3D bioprinting market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on 3D Bioprinting Market
5.1. COVID-19 Landscape: 3D Bioprinting Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global 3D Bioprinting Market, By Component
8.1. 3D Bioprinting Market, by Component, 2022-2030
8.1.1. 3D Bioprinters
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Bioinks
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global 3D Bioprinting Market, By Technology
9.1. 3D Bioprinting Market, by Technology, 2022-2030
9.1.1. Magnetic Levitation
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Inkjet-based
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Syringe-based
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Laser-based
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global 3D Bioprinting Market, By Application
10.1. 3D Bioprinting Market, by Application, 2022-2030
10.1.1. Research Applications
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Clinical Applications
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global 3D Bioprinting Market, By End User
11.1. 3D Bioprinting Market, by End User, 2022-2030
11.1.1. Research Organizations and Academic Institutes
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Biopharmaceutical companies
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Hospitals
11.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global 3D Bioprinting Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Component (2017-2030)
12.1.2. Market Revenue and Forecast, by Technology (2017-2030)
12.1.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.4. Market Revenue and Forecast, by End User (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End User (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End User (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End User (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End User (2017-2030)
Chapter 13. Company Profiles
13.1. 3D Bioprinting Solutions
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Advanced Solutions Life Sciences, LLC
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Allevi Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Aspect Biosystems Ltd.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Bico group ab
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Bio3D Technologies Pte. Ltd.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Cellink Global
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Collplant Biotechnologies Ltd.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Cyfuse Biomedical K.K.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Electro Optical Systems
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments